Company / R&D per Share
PROTHENA CORP PUBLIC LTD CO R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$4.10
FY2025
5-year range
$1.27 / $4.10
FY2021-FY2025
Trend
+62.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 10 years, ranging from $1.21 in FY2016 to $4.10 in FY2025.
Based on SEC 10-K filings.
4.10 in FY2025 with a 5-year CAGR of +10.1%.
Improved from $1.58 to $4.10 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +36.7%
- 5-Year CAGR
- +10.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 62.3% year-over-year.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.10 | +62.3% |
| FY2024 | $2.53 | +59.9% |
| FY2023 | $1.58 | -1.6% |
| FY2022 | $1.60 | +26.0% |
| FY2021 | $1.27 | -49.8% |
| FY2020 | $2.54 | -24.9% |
| FY2019 | $3.38 | +8.7% |
| FY2018 | $3.11 | +84.7% |
| FY2017 | $1.68 | +38.8% |
| FY2016 | $1.21 | +27.3% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 28, 2026